Organotypic human airway tissue models are potentially useful tools for the early phases of inhalation pharmaceutical development programs.
This article briefly reviews the application of organotypic in vitro tissue culture models for assessing drug disposition, toxicity and efficacy of inhalable formulations intended for administration via the proximal airways.